LYTIR

Company · OTLK

Outlook Therapeutics, Inc.

Nasdaq's symbol directory lists OTLK on Nasdaq as “Outlook Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 4 occasions (at least $2.5M); 3 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $2.6M in total; Insider sales: $0 in total.Jul: Insider purchases $100KAug: Insider purchases $2.5MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $2.6MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Ghiath M. Sukhtian bought on 1 day latest Aug 12, 2026 bought $2.5M
  2. Sukhtian Faisal Ghiath bought on 1 day latest Jul 29, 2026 bought $100K
  3. Jahr Robert Charles, Chief Executive Officer bought on 1 day latest Aug 14, 2026 value not filed
  4. KENYON LAWRENCE A, Chief Financial Officer bought on 1 day latest Aug 14, 2026 value not filed
Every trade (4)
  1. BUYJahr Robert Charles, Chief Executive Officer bought Aug 14, 2026 151,515 shares filing —
  2. BUYKENYON LAWRENCE A, Chief Financial Officer bought Aug 14, 2026 101,010 shares filing —
  3. BUYGhiath M. Sukhtian bought Aug 12, 2026 2,525,252 shares filing $2.5M
  4. BUYSukhtian Faisal Ghiath bought Jul 29, 2026 95,398 shares filing $100K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Empery Asset Management, LP filed Oct 13, 2026 Schedule 13G passive filing 8.73%
  2. CVI Investments, Inc. filed Aug 19, 2026 Schedule 13G passive filing 9.9%
  3. GMS Ventures & Investments filed Aug 14, 2026 Schedule 13D/A may seek influence 42,631,142 shares filing 16.4%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Notice of delisting or failure to meet a listing standard filing Sep 30, 2026
  2. Other events filing Sep 18, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.